Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant

Environmental Health Perspectives

Volumn 121, Issue 11-12, 2013, Pages 1313-1318

  Barry, Vaughn ^a   Winquist, Andrea ^a   Steenland, Kyle ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUOROOCTANOIC ACID;

ADULT; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TESTIS CANCER; THYROID CANCER; VALIDATION PROCESS;

ADULT; CAPRYLATES; CHEMICAL INDUSTRY; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; FLUOROCARBONS; HUMANS; INCIDENCE; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; WATER POLLUTANTS, CHEMICAL; WEST VIRGINIA;

EID: 84888396390     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1306615     Document Type: Article

References (35)

1. Armstrong BG. 1998. Effect of measurement error on epidemiological studies of environmental and occupational exposures. Occup Environ Med 55(10):651-656.
2. Bergmann MM, Calle EE, Mervis CA, Miracle-McMahill HL. 1998. Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol 147(6):556-562.
3. Biegel LB, Hurtt ME, Frame SR, O'Connor JC, Cook JC. 2001. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol Sci 60(1):44-55.
4. Bonefeld-Jorgensen EC, Long M, Bossi R, Ayotte P, Asmond G, Krüger T, et al. 2011. Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study. Environ Health 10:88; doi:10.1186/1476-069X-10-88.
5. Butenhoff J, Costa G, Elcombe C, Farrar D, Hansen K, Iwai H, et al. 2002. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 69(1):244-257.
6. C8 Health Project. 2012. C8 Health Project Homepage. Available: http://publichealth.hsc.wvu.edu/c8/ [accessed 5 February 2013].
7. C8 Science Panel. 2012. C8 Science Panel Homepage. Available: http://www.c8sciencepanel.org/index.html [accessed 5 February 2013].
8. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. 2007. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115:1596-1602; doi:10.1289/ehp.10598.
9. DeWitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D, Frame SR, et al. 2009. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 39(1):76-94.
10. Eriksen KT, Sørensen M, McLaughlin JK, Lipworth L, Tiønneland A, Overvad K, et al. 2009. Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J Natl Cancer Inst 101(8):605-609.
11. Frisbee SJ, Brooks AP, Maher A, Flensborg P, Arnold S, Fletcher T, et al. 2009. The C8 Health Project: design, methods, and participants. Environ Health Perspect 117:1873-1882; doi:10.1289/ehp.0800379.
12. Han X, Kemper RA, Jepson GW. 2005. Subcellular distribution and protein binding of perfluorooctanoic acid in rat liver and kidney. Drug Chem Toxicol 28(2):197-209.
13. Kennedy G, Butenhoff J, Olsen G, O'Connor JC, Seacat AM, Perkins RG, et al. 2004. The toxicology of perfluorooctanoate. Crit Rev Toxicol 34(4):351-384.
14. Koeffler HP. 2003. Peroxisome proliferator-activated receptor γ and cancers. Clin Cancer Res. 9(1):1-9.
15. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99(2):366-394.
16. Leonard RC, Kreckmann KH, Sakr CJ, Symons JM. 2008. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 18(1):15-22.
17. Lundin JI, Alexander BH, Olsen GW, Church TR. 2009. Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 20(6):921-928.
18. National Cancer Institute. 2012. Surveillance Epidemiology and End Results. SEER Stat Fact Sheets: Kidney and Renal Pelvis Cancer. Available: http://seer.cancer.gov/statfacts/ html/kidrp.html#survival [accessed 5 February 2013].
19. National Center for Health Statistics. 2006. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Available: http://www.cdc.gov/ nchs/icd/icd9cm.htm [accessed 16 September 2013].
20. Olsen GW, Burris J, Ehresman D, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perluorohexanesulfonate, and perefluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298-1365; doi:10.1289/ehp.10009.
21. Seals R, Bartell SM, Steenland K. 2011. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community. Environ Health Perspect 119:119-124; doi:10.1289/ehp.1002346.
22. Shin HM, Vieira VM, Ryan PB, Detwiler R, Sanders B, Steenland K, et al. 2011a. Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works facility in West Virginia. Environ Sci Technol 45(4):1435-1442.
23. Shin HM, Vieira VM, Ryan PB, Steenland K, Bartell SM. 2011b. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Environ Health Perspect 119:1760-1765; doi:10.1289/ehp.1103729.
24. Stavrou E, Vajdic CM, Loxton D, Pearson S. 2011. The validity of self-reported cancer diagnoses and factors associated with accurate reporting in a cohort of older Australian women. Cancer Epidemiol 35(6):e75-e80.
25. Steenland K, Deddens JA, Zhao S. 2000. Biases in estimating the effect of cumulative exposure in log-linear models when estimated exposure levels are assigned. Scand J Work Environ Health 26(1):37-43.
26. Steenland K, Fletcher T, Savitz DA. 2010. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 118:1100-1108; doi:10.1289/ ehp.0901827.
27. Steenland K, Jin C, MacNeil J, Lally C, Ducatman A, Vieira V, et al. 2009. Predictors of PFOA levels in a community surrounding a chemical plant. Environ Health Perspect 117:1083-1088; doi:10.1289/ehp.0800294.
28. Steenland K, Woskie S. 2012. Cohort mortality study of workers exposed to perfluorooctanoic acid. Am J Epidemiol 176(10):909-917.
29. Suchanek KM, May FJ, Robinson JA, Lee WJ, Holman NA, Monteith GR, et al. 2002. Peroxisome proliferator-activated receptor α in the human breast cancer cell lines MCF-7 and MDA-MB-231. Mol Carcinog 34(4):165-171.
30. U.S. Environmental Protection Agency. 2005. Draft Risk Assessment of the Potential Human Health Effects Associated with Exposure to Perfluoroctanoic Acid and Its Salts. Available: http://www.epa.gov/oppt/pfoa/pubs/ pfoarisk.pdf [accessed 5 February 2013].
31. U.S. Environmental Protection Agency. 2006. Advisory Board Review of EPA's Draft Risk Assessment of Potential Human Health Effects Associated with PFOA and Its Salts. EPA-SAB-06-006. Available: http://yosemite.epa.gov/sab/ sabproduct.nsf/A3C83648E77252828525717F004B9099/$File/ sab_06_006.pdf [accessed 5 February 2013].
32. Vieira VM, Hoffman K, Shin H-M, Weinberg JM, Webster TF, Fletcher T. 2013. Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis. Environ Health Perspect 121:318-323; doi:10.1289/ehp.1205829.
33. Winquist A, Steenland K. 2012. Association between cumulative PFOA exposure and thyroid disease in community and worker cohorts [Abstract]. Epidemiology 23(5S):S121.
34. World Health Organization. 1992. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva:WHO. Available: http://apps.who. int/classifications/icd10/browse/2010/en [accessed 16 September 2013].
35. Woskie SR, Gore R, Steenland K. 2012. Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant. Ann Occup Hyg Apr 26:1-13.